TransMedics (TMDX) FCF Margin (2018 - 2026)
TransMedics' (TMDX) quarterly FCF Margin came in at 6.97% in Q1 2026, up 1386.0% year-on-year from 0.47% in Q1 2025, and down 158.98% quarter-over-quarter from 11.82% in Q4 2025.
TransMedics (TMDX) FCF Margin (2018 - 2026) Analysis & Trends
TransMedics' FCF Margin history runs 9 years deep, the most recent figure standing at 6.97% for Q1 2026.
- On a quarterly basis, FCF Margin rose 1386.0% year-over-year to 6.97% in Q1 2026; TTM through Mar 2026 was 23.8%, a 1021.0% increase from a year earlier, with the FY2025 full-year figure at 22.06%, up 1104.0% from the prior year.
- FCF Margin slipped to 6.97% in Q1 2026 per TMDX's latest filing, from 11.82% in the prior quarter.
- Across five years, FCF Margin topped out at 111.53% in Q4 2024 and bottomed at 176.77% in Q4 2023.
- The 5-year median for FCF Margin is 20.83% (2025), against an average of 23.23%.
- Across the five-year window, FCF Margin sank 15510 bps in 2023 and jumped 28830 bps in 2024, its largest moves.
- Year by year, FCF Margin stood at 21.67% in 2022, then sank by 716 bps to 176.77% in 2023, then soared by 163 bps to 111.53% in 2024, then slumped by 89 bps to 11.82% in 2025, then tumbled by 159 bps to 6.97% in 2026.
- Per Business Quant, the three latest TMDX FCF Margin figures stand at 6.97% (Q1 2026), 11.82% (Q4 2025), and 17.97% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -1.28% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 37.67% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.68% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.18% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | TransMedics | 2.45 Bn | 1.98 Bn | 101.16 Mn | -6.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.97% |
| Dec 31, 2025 | 11.82% |
| Sep 30, 2025 | 17.97% |
| Jun 30, 2025 | 75.39% |
| Mar 31, 2025 | -20.83% |
| Dec 31, 2024 | 111.53% |
| Sep 30, 2024 | -100.46% |
| Jun 30, 2024 | 61.12% |
| Mar 31, 2024 | -49.16% |
| Dec 31, 2023 | -176.77% |
| Sep 30, 2023 | -10.31% |
| Jun 30, 2023 | -9.43% |
| Mar 31, 2023 | -23.07% |
| Dec 31, 2022 | -21.67% |
| Sep 30, 2022 | -86.04% |
| Jun 30, 2022 | -46.21% |
| Mar 31, 2022 | -121.82% |
| Dec 31, 2021 | -114.98% |
| Sep 30, 2021 | -175.40% |
| Jun 30, 2021 | -66.94% |